Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19

SARS-CoV-2 antigen tests used at the point-of-care, such as the Abbott Panbio, have great potential to help combat the COVID-19 pandemic. The Panbio is Health Canada approved for the detection of SARS-CoV-2 in symptomatic individuals within the first 7 days of COVID-19 symptom onset(s). Symptomatic...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur J Clin Microbiol Infect Dis
Päätekijät: Stokes, William, Berenger, Byron M., Portnoy, Danielle, Scott, Brittney, Szelewicki, Jonas, Singh, Takshveer, Venner, Allison A., Turnbull, LeeAnn, Pabbaraju, Kanti, Shokoples, Sandy, Wong, Anita A., Gill, Kara, Guttridge, Tracy, Proctor, Dustin, Hu, Jia, Tipples, Graham
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Berlin Heidelberg 2021
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7979467/
https://ncbi.nlm.nih.gov/pubmed/33742322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10096-021-04202-9
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia